October 28, 2025

Wave Life Sciences Ltd. (WVE) Stock Report: Assessing the 159.84% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, has captured the attention of investors with its promising RNA medicine platform, PRISM. As a clinical-stage..

The Pennant Group, Inc. (PNTG) Stock Analysis: A 30% Upside Potential Draws Investor Attention

The Pennant Group, Inc. (PNTG), a prominent player in the healthcare sector, is making waves with its projected 30.64% upside, making it a stock worth watching..

Integra LifeSciences Holdings C (IART)

⚠️ No article content returned.

..

CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a 53% Upside Potential in the Biotech Sector

Investors with an eye for promising opportunities in the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) a compelling prospect. Specializing in innovative treatments for..

NeoGenomics, Inc. (NEO) Stock Analysis: 8.27% Potential Upside with Robust Revenue Growth

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the healthcare sector, is drawing significant attention from investors due to its focus on cancer diagnostics and research...

Dyne Therapeutics (DYN) Stock Analysis: Exploring a 42.86% Upside in the Biotechnology Sector

Investors with a keen eye on the biotechnology sector should pay close attention to Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage company focused on revolutionizing treatments..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Promising 109% Potential Upside

Mesoblast Limited (NASDAQ: MESO), a prominent player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 109.46%. Trading at $16.71, the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating Growth with a Unique Market Position and Analyst Confidence

Guardian Pharmacy Services, Inc. (NYSE: GRDN), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has been making waves with its..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Analyzing a 42.86% Potential Upside in the Healthcare Sector

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at a unique crossroads in the healthcare sector, offering individual investors an intriguing blend of risk and reward. With its..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 35% Upside Potential in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a dynamic player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a current market..

Disc Medicine, Inc. (IRON) Stock Analysis: A 20% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a dynamic player in the biotechnology sector, has caught the attention of investors with its robust product pipeline and promising financial..

Evotec SE (EVO) Stock Analysis: Navigating a Potential 32.76% Upside in the Healthcare Sector

Evotec SE (EVO), a prominent player in the healthcare sector, is currently drawing significant attention from investors keen on its potential upside. With its stock price..

Evolent Health, Inc (EVH) Stock Analysis: A 102% Potential Upside Amidst Healthcare Sector Challenges

Evolent Health, Inc. (NYSE: EVH) is a compelling player within the healthcare sector, specifically in the niche of health information services. With a market capitalization of..

Novavax, Inc. (NVAX) Stock Analysis: Unpacking a 51.85% Upside Potential and the Road Ahead

Novavax, Inc. (NASDAQ: NVAX) is a name that continues to draw considerable attention within the biotechnology sector, particularly for investors eyeing significant potential upside. With a..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A Closer Look at the 21.95% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX), a global biopharmaceutical company, has been capturing investor attention, not only for its diverse range of pharmaceutical products but also for its..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a 69.70% Potential Upside in the Biotechnology Sector

Viridian Therapeutics, Inc. (VRDN), a prominent player in the biotechnology sector, has been making waves with its innovative approach to developing treatments for serious and rare..

Opko Health, Inc. (OPK): Analyst Ratings Shine with 150% Potential Upside Amidst Current Challenges

Opko Health, Inc. (OPK), a prominent player in the healthcare sector, is drawing significant attention from investors, especially with its analyst ratings projecting a striking 150%..

CONMED Corporation (CNMD) Stock Analysis: Unveiling a 28.8% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD), a distinguished player in the medical devices industry, presents an intriguing opportunity for investors with its substantial 28.8% potential upside. Headquartered in..

Schrodinger, Inc. (SDGR): Analyst Ratings Reveal a 21.79% Upside Potential

Investors looking to capitalize on innovation in healthcare technology should take a closer look at Schrodinger, Inc. (NASDAQ: SDGR). With a market capitalization of $1.63 billion,..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Exploring a 17.58% Potential Upside

Savvy investors seeking promising opportunities in the healthcare sector should take a closer look at U.S. Physical Therapy, Inc. (NYSE: USPH). With its solid footing in..

Search

Funds

October 28, 2025

Search

Funds

October 28, 2025

FTSE 100

Funds